Chagas Disease Management Market Projected To Grow With Significant CAGR Over The Forecast Period

28/mag/2018 11:01:48 pbi Contatta l'autore

Questo comunicato è stato pubblicato più di 6 mesi fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Chagas Disease Management Market Projected To Grow With Significant CAGR Over The Forecast Period

Global chagas disease management market: Chagas disease or American trypanosomiasis is a tropical parasitic disease caused by Trypanosoma cruzi. It is transmitted by kissing bugs or triatomine bugs. It can also be transmitted through blood transfusions, in pregnancy, and organ transplantation. In early stage of the Chagas disease, the symptoms include swollen lymph nodes, fever, headache, and local swelling at the site of the bite. The chronic symptoms will appear after 8-12 weeks that may include expansion of ventricles leading to heart failure, irregular heartbeat, difficulty in swallowing, and abdominal or colon pain.

 

Rise in the prevalence of Chagas disease due to unhygienic conditions are factors leading to the growth of market. In addition, increase in the R & D of new products are one of the main factors for the market growth. However, lack of awareness regarding the Chagas disease treatment, a limited number of approved products in the current market, and supply chain issues with Chagas disease drugs will hamper the market growth.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-chagas-disease-management-market/#ulp-4H8Z4LpNMLEuOnnx

 

The Chagas disease management market is categorized as under-

1.      Type of treatment

·         Anti-parasitic treatment

·         Symptomatic treatment

2.     Drug type

·         Benznidazole

·         Nifurtimox

3.     End-users

Hospital, Online and retail pharmacies

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-chagas-disease-management-market/#ulp-c654SbFYO64MsOhu

 

And lastly, on the basis of geographical regions, the Chagas disease management market have five major regions- North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Latin America is the major center for Chagas disease and gradually developing in the rest of world owing to the population mobility from Latin America. Less number of products available in the market for treatment, and poor diagnostic methods to detect in the Latin America region are the major challenges for the Chagas disease management market in this region. North America and Europe are the key regions for Chagas disease management market owing to increase in the prevalence of Chagas disease.

 

Some of the key players in Chagas disease management market are AstraZeneca (U.K), Bayer AG (Germany), Daiichi Sankyo Company Ltd (Japan), Eisai Co Ltd (Japan), GlaxoSmithKline Plc. (U.K), Grupo Praxis Pharmaceutical SA (Spain), Kancera AB (Sweden), Novartis AG (Switzerland), Laboratorio Elea S.A.C.I.F. y A (Argentina), Oblita Therapeutics BVBA (Belgium), and Sanofi Aventis (France) to name a few. In 2017, Daiichi Sankyo Company Limited and Drugs for Neglected Diseases initiative (DNDi) are collaborated to form a joint research with regard to a new research program, the hit-to-lead project to develop the drugs for Chagas disease and Leishmaniasis.

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-chagas-disease-management-market/#ulp-14mlyhjMGhVjZqa3

 

 

Chagas disease management market is still in the budding stage. Currently, very few players are actively involved in the development of new products for the treatment. Several products are in pipeline that may enter the market near future.  Increase in R & D for new products, acquisitions & mergers, collaborations and providing funds to various organizations can fuel the market growth for Chagas disease. For instance, in 2012, Japan’s Astellas Pharma signed an agreement with the Drugs for Neglected Diseases initiative (DNDi) to collaborate on drug discovery research for three neglected tropical diseases: leishmaniasis, Chagas disease, and sleeping sickness.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-chagas-disease-management-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

 

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl